Literature DB >> 24920723

Fibroblast growth factor 23: a novel key to find hidden substrates of atrial fibrillation?

Anuradha Kalyanasundaram1, Vadim V Fedorov2.   

Abstract

Entities:  

Keywords:  Editorials; atrial fibrillation; fibroblast growth factor 23; fibrosis; renal insufficiency, chronic; vitamin D

Mesh：

Substances：

Year:  2014        PMID： 24920723      PMCID： PMC4136658          DOI： 10.1161/CIRCULATIONAHA.114.011034

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

Review 2.  Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.

Authors:  Jordi Heijman; Niels Voigt; Stanley Nattel; Dobromir Dobrev
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.

Authors:  L Darryl Quarles
Journal:  Exp Cell Res       Date:  2012-03-07       Impact factor: 3.905

4.  The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.

Authors:  Laura M G Meems; Megan V Cannon; Hasan Mahmud; Adriaan A Voors; Wiek H van Gilst; Herman H W Silljé; Willem P T Ruifrok; Rudolf A de Boer
Journal:  J Steroid Biochem Mol Biol       Date:  2012-07-16       Impact factor: 4.292

5.  Atrial fibrillation epidemic and hospitalizations: how to turn the rising tide?

Authors:  Christopher X Wong; Dennis H Lau; Prashanthan Sanders
Journal:  Circulation       Date:  2014-05-19       Impact factor: 29.690

6.  Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.

Authors:  Alexey V Glukhov; Anuradha Kalyanasundaram; Qing Lou; Lori T Hage; Brian J Hansen; Andriy E Belevych; Peter J Mohler; Björn C Knollmann; Muthu Periasamy; Sandor Györke; Vadim V Fedorov
Journal:  Eur Heart J       Date:  2013-11-11       Impact factor: 29.983

7.  Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules.

Authors:  Michel Baum; Susan Schiavi; Vangipuram Dwarakanath; Raymond Quigley
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

8.  Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23.

Authors:  Ken-ichi Miyamoto; Mikiko Ito; Masashi Kuwahata; Shigeaki Kato; Hiroko Segawa
Journal:  Ther Apher Dial       Date:  2005-08       Impact factor: 1.762

9.  FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

Authors:  Chad D Touchberry; Troy M Green; Vladimir Tchikrizov; Jaimee E Mannix; Tiffany F Mao; Brandon W Carney; Magdy Girgis; Robert J Vincent; Lori A Wetmore; Buddhadeb Dawn; Lynda F Bonewald; Jason R Stubbs; Michael J Wacker
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

Review 10.  Management of atrial fibrillation in chronic kidney disease: double trouble.

Authors:  Camus Nimmo; Matthew Wright; David Goldsmith
Journal:  Am Heart J       Date:  2013-06-15       Impact factor: 4.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.